3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Dermatologic
1
Conditions
Breast Neoplasms
214
Neoplasms
197
Carcinoma, Non-Small-Cell Lung
91
Colorectal Neoplasms
89
Prostatic Neoplasms
78
Lung Neoplasms
75
Multiple Myeloma
49
Head and Neck Neoplasms
47
Melanoma
46
Pancreatic Neoplasms
45
Neoplasm Metastasis
44
Leukemia, Myeloid, Acute
41
Carcinoma, Hepatocellular
41
Recurrence
37
Brain Neoplasms
37
Squamous Cell Carcinoma of Head and Neck
34
Ovarian Neoplasms
32
Glioblastoma
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Glioma
29
Uterine Cervical Neoplasms
27
Sarcoma
27
Stomach Neoplasms
26
Lymphoma, Non-Hodgkin
26
Lymphoma
26
Carcinoma, Renal Cell
26
Motor Activity
24
Lymphoma, Follicular
24
Colonic Neoplasms
23
Lymphoma, Large B-Cell, Diffuse
22
Interventions
tirbanibulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Keratosis
×
90 days
×
Clear all
NCT06135415
2026-03-25
TirbAKare
Almirall, S.A.
Phase 3
Completed
280 enrolled